Cargando…

Hemophilia in Patients 50 Years or Older: Quality of Life, Health Maintenance, Cancer Screening and COVID19

INTRODUCTION: Major progress has been made in treatment of patients with hemophilia over the last 30 or 40 years. Factor replacement, eliminating HIV and hepatitis C transmission, and more recently, longer-acting coagulation factors and immune treatments play a role in allowing patients with hemophi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katiyar, Vatsala, Day, Mackenzie, Schum, Mandy, Gaslin, Tracey, Brown, Racquel, Radulescu, Vlad Calin, Cisak, Kamila I., Munker, Reinhold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	322.Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701470/ http://dx.doi.org/10.1182/blood-2021-149814

Ejemplares similares

Study of Coagulopathies in Covid 19 Positive Patients & Their Correlation with Outcome of Disease
por: Khunger, Jitender, et al.
Publicado: (2020)

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
por: Madeeva, Daria V, et al.
Publicado: (2020)

COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting
por: Gadde, Saikrishna, et al.
Publicado: (2020)

Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease
por: Thomas, Mari, et al.
Publicado: (2020)

Venous Thromboembolic Disease in Children Associated with COVID-19
por: Narang, Shalu, et al.
Publicado: (2020)

Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19
por: Yang, Mo, et al.
Publicado: (2020)

Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study
por: Crowther, Mark, et al.
Publicado: (2020)

THE EFFECT OF THE COVID-19 PANDEMIC PROCESS ON TREATMENT COMPLIANCE IN HEMOPHILIA PATIENTS
por: Şahin, Şifa, et al.
Publicado: (2022)

Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children: Results of a Phase 3 Trial
por: Kenet, Gili, et al.
Publicado: (2016)

Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network
por: Whyte, Claire S., et al.
Publicado: (2016)

Impact of Fibrinogen Carbamylation on Fibrin Clot Formation and Stability
por: Binder, Veronika, et al.
Publicado: (2017)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Are Cardiovascular Risk Factors also Associated with the Incidence of Atrial Fibrillation?: A Systematic Review and Field Synopsis of 23 Factors in 32 Population-Based Cohorts of 20 Million Participants
por: Allan, Victoria, et al.
Publicado: (2017)

Platelet Turnover Predicts Outcome after Coronary Intervention
por: Freynhofer, Matthias K., et al.
Publicado: (2017)

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
por: Patel, Rachna, et al.
Publicado: (2021)

Rapid Disappearance of Lupus Anticoagulant in Novel Coronavirus 2019 Patients; Is It the Key to Pandora's Box?
por: Kim, Hyunji, et al.
Publicado: (2021)

In Covid-19 Infection, Plasma Extracellular Vesicle Tissue Factor Activity Does Not Correlate with D-Dimer Levels
por: Girard, Thomas J., et al.
Publicado: (2021)

A Case Series of Acquired Factor Inhibitor Following Sars-COV2-Vaccination
por: Jayananda, Sriraksha
Publicado: (2021)

Novel, high incidence exercise-induced muscle bleeding model in hemophilia B mice: rationale, development and prophylactic intervention
por: Tranholm, M, et al.
Publicado: (2015)

Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A
por: Nguyen, G. N., et al.
Publicado: (2016)

Profil épidémiologique de la COVID-19 du 15 mars 2020 au 15 mars 2022 à l’Établissement hospitalier universitaire régional de la Sûreté Nationale d'Oran
por: Boukhari, H., et al.
Publicado: (2022)

Fibrinolysis in a lipid environment: modulation through release of free fatty acids
por: RÁBAI, G, et al.
Publicado: (2007)

Hindered dissolution of fibrin formed under mechanical stress
por: Varjú, I, et al.
Publicado: (2011)

Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
por: Mutch, N J, et al.
Publicado: (2010)

Lytic and mechanical stability of clots composed of fibrin and blood vessel wall components
por: Rottenberger, Z, et al.
Publicado: (2013)

Leukemia‐associated Rho guanine‐nucleotide exchange factor is not critical for RhoA regulation, yet is important for platelet activation and thrombosis in mice
por: Williams, C. M., et al.
Publicado: (2015)

Increased urokinase and consumption of α(2)‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay
por: Longstaff, C., et al.
Publicado: (2018)

On the localization of the cleavage site in human alpha‐2‐antiplasmin, involved in the generation of the non‐plasminogen binding form
por: Abdul, Shiraazkhan, et al.
Publicado: (2020)

VhH anti‐thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow
por: van Moorsel, Marc V. A., et al.
Publicado: (2022)

The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice.
por: Bou-Jaoudeh, Melissa, et al.
Publicado: (2023)

A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X
por: TAI, S J, et al.
Publicado: (2008)

The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model
por: SU, E J, et al.
Publicado: (2011)

Redox control of β(2)-glycoprotein I–von Willebrand factor interaction by thioredoxin-1
por: PASSAM, F H, et al.
Publicado: (2010)

Biochemical and functional characterization of a recombinant monomeric factor VIII–Fc fusion protein
por: PETERS, R T, et al.
Publicado: (2013)

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)

Coagulation factor XII protease domain crystal structure
por: Pathak, M, et al.
Publicado: (2015)

Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage
por: Herzog, E., et al.
Publicado: (2015)

Plasma free fatty acid levels influence Zn(2+)-dependent histidine-rich glycoprotein–heparin interactions via an allosteric switch on serum albumin
por: Kassaar, O, et al.
Publicado: (2015)

An engineered U1 small nuclear RNA rescues splicing-defective coagulation F7 gene expression in mice
por: Balestra, D, et al.
Publicado: (2014)

A simple flow cytometry method improves the detection of phosphatidylserine-exposing extracellular vesicles
por: Arraud, N, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_npog0d8o61967buum4evj86pqe